Skip to main content

and
  1. No Access

    Article

    Role of corticosteroids in prostate cancer progression: implications for treatment strategy in metastatic castration-resistant patients

    Corticosteroid agents (CA) are widely used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) either as concomitant treatment with active agents such as docetaxel, cabazitaxel and abir...

    S. Sideris, F. Aoun, C. N. Martinez in Journal of Endocrinological Investigation (2016)